Fund
S32
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 3
- Lead
- 1
- New entries
- 1
- Follow ons
- 1
- Latest operation
- 24 September 2026
- Sectors
- Biotech, Diagnostics
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 24 Sept | United States, Biotech | Series C | 75 M$ | Existing investor |
| 23 Sept | United Kingdom, Biotech | Series C | 140 M$ | Lead |
| 07 Apr | United States, Diagnostics | Series B | 97 M$ | Participant |
Co investors 39 funds crossed
- Catalio Capital Management 3 operations
- 8VC 1 operation
- Alexandria Venture Investments 1 operation
- Amgen Ventures 1 operation
- André Hoffmann, vice-président de Roche, à titre personnel 1 operation
- Andreessen Horowitz 1 operation
- Anthology Fund (Anthropic) 1 operation
- Casdin Capital 1 operation
- DFJ Growth 1 operation
- Discovery Ventures 1 operation
- Eli Lilly and Company 1 operation
- European Tech Collective 1 operation
- Firebrand River Capital 1 operation
- General Catalyst 1 operation
- GRIDS Capital 1 operation
- GV 1 operation
- Inception Fund 1 operation
- Indicator Ventures 1 operation
- Innoviva 1 operation
- Intermountain Ventures 1 operation
- JSL Health 1 operation
- Kicker Ventures 1 operation
- King Philanthropies 1 operation
- LG Technology Ventures 1 operation
- Logos Capital 1 operation
- Merck Global Health Innovation Fund 1 operation
- NATO Innovation Fund 1 operation
- NVIDIA 1 operation
- Palo Santo VC 1 operation
- PostScriptum 1 operation
- Premji Invest 1 operation
- Quadrille Capital 1 operation
- Redalpine 1 operation
- Samsung Next 1 operation
- Sigmas Group 1 operation
- Singular 1 operation
- Sovereign AI 1 operation
- The Rockefeller Foundation 1 operation
- True Ventures 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States, United Kingdom.